Sodium Acetate Injection
Last Updated: December 2, 2022
Status: Current
Products Affected - Description
-
- Sodium acetate injection, Fresenius Kabi, 4 mEq/mL, 100 mL vial, 20 count, NDC 63323-0032-00
- Sodium acetate injection, Pfizer, 2 mEq/mL, 100 mL vial, 25 count, NDC 00409-3299-06
- Sodium acetate injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-7299-73
- Sodium acetate injection, Pfizer, 2 mEq/mL, 50 mL vial, 25 count, NDC 00409-3299-05
Reason for the Shortage
-
- Fresenius Kabi has sodium acetate injection on shortage due to increased demand.
- Pfizer has sodium acetate injection on shortage due to production delays from a component of a third-party supplier.
- Woodward Pharma did not provide a reason for the shortage.
Available Products
-
- Sodium acetate injection, Woodward, 2 mEq/mL, 100 mL vial, 1 count, NDC 69784-0231-20
- Sodium acetate injection, Woodward, 2 mEq/mL, 50 mL vial, 1 count, NDC 69784-0230-20
Estimated Resupply Dates
-
- Fresenius Kabi has sodium acetate 4 mEq/mL 100 mL vials on back order and the company cannot estimate a release date.
- Pfizer has sodium acetate 2 mEq/mL 20 mL, 50 mL, and 100 mL vials on back order and the company estimates a release date of January 2023.
Updated
Updated December 2, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 1, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.